http://news.poseidon-us.com/TCyPB1
In a first-of-its-kind clinical trial, a team leveraged an artificial intelligence-derived platform to guide treatment for a patient with a rare blood cancer.
http://news.poseidon-us.com/TCyPB1
http://news.poseidon-us.com/TCyPB1